Trial · NCT04509193
Registered outcomes25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 25
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of stroke or systemic embolism | Up to 8 years | |
| Primary | Any major or clinically-relevant nonmajor bleed resulting in hospitalization | Up to 8 years | |
| Secondary | Ischemic stroke | Up to 8 years | |
| Secondary | Systemic embolism | Up to 8 years | |
| Secondary | Need for revascularization or major amputation of the lower limb | Up to 8 years | |
| Secondary | Intracranial hemorrhage | Up to 8 years | |
| Secondary | Critical organ bleeding per ISTH categories | Up to 8 years | The categories for critical organ bleeding as per ISTH definition are: intracranial, intraspinal, intraocular, retroperitoneal, intra-articular or pericardial, or intramuscular with compartment syndrome. |
| Secondary | Any extracranial bleeding | Up to 8 years | |
| Secondary | Any hospitalization due to intracranial or critical organ bleeding or a bleed in another location associated with either a 2 g/dL drop in hemoglobin or need for transfusion | Up to 8 years | |
| Secondary | Doubling of the serum creatinine level from baseline | Up to 8 years | |
| Secondary | Decrease in eGFR>30% or 40% | Up to 8 years | Glomerular filtration rate (GRF) |
| Secondary | Development of an eGFR<15 mL/min or initiation of dialysis | Up to 8 years | Glomerular filtration rate (GRF) |
| Secondary | Development of end-stage renal disease per billing codes only | Up to 8 years | |
| Secondary | Development of urine albumin-to-creatinine ratio (UACR) of 30-300 or >300 | Up to 8 years | |
| Secondary | Development of serum potassium > 5.6 or >6 mg/dL | Up to 8 years | |
| Secondary | Development of diabetic retinopathy | Up to 8 years | |
| Secondary | Myocardial infarction | Up to 8 years | |
| Secondary | All-cause mortality | Up to 8 years | |
| Secondary | Vascular mortality | Up to 8 years | |
| Secondary | Major adverse cardiovascular event | Up to 8 years |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04509193/registered